Journal of Clinical Endocrinology & Metabolism, Vol 78, 180-187, Copyright © 1994 by Endocrine Society

ARTICLES

Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas

TH Jones, M Daniels, RA James, SK Justice, R McCorkle, A Price, P Kendall- Taylor and AP Weetman
University Department of Medicine, Northern General Hospital, Sheffield, England.

Preliminary studies have demonstrated that some pituitary adenomas secrete immunoreactive interleukin-6 (irIL-6) when cultured in vitro. We have extended these studies by investigating 100 pituitary adenomas of different types measuring immunoreactive and bioactive IL-6. Tumors were cultured either as explants without fetal calf serum or as dispersed cells with 10% total calf serum. Fifty-three of the 100 (53%) pituitary cultures were found to release irIL-6 and in 44 adenomas examined, 32 (72.7%) secreted bioactive IL-6. In 61 explant cultures, 30 adenomas released IL-6, indicating autonomous secretion. The amount of IL-6 released by adenomas in cell culture was generally higher, although the incidence was similar to explant cultures. IrIL-6 was released by 7 of 14 prolactinomas, 15 of 27 somatotrophinomas, 5 of 7 corticotrophinomas (including 2 Nelson's adenomas), 1 of 1 thyrotrophinomas, 2 of 2 gonadotrophinomas, and 23 of 49 clinically non- functioning adenomas. Periadenomatous tissue removed from a patient with a corticotrophinoma was found to secrete IL-6 but in much lower concentration than from the adenoma tissue. Tumor necrosis factor-alpha and -gamma-interferon were not detected in the conditioned media. Four IL-6-secreting adenomas were examined by in situ hybridization for IL-6 messenger RNA, and three of these were positive with fluorescence present throughout the tissue examined. We have provided evidence that over half of pituitary adenomas secrete IL-6 which is bioactive and that IL-6 is synthesized within the tumor by the adenoma cells.

This article has been cited by other articles:

				F.-y. Gong, Y.-f. Shi, and J.-y. Deng The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells. J. Endocrinol., August 1, 2006; 190(2): 397 - 406. [Abstract] [Full Text] [PDF]

				W. Allaerts and H. Vankelecom History and perspectives of pituitary folliculo-stellate cell research Eur. J. Endocrinol., July 1, 2005; 153(1): 1 - 12. [Abstract] [Full Text] [PDF]

				S A Borg, K E Kerry, J A Royds, R D Battersby, and T H Jones Correlation of VEGF production with IL1{alpha} and IL6 secretion by human pituitary adenoma cells Eur. J. Endocrinol., February 1, 2005; 152(2): 293 - 300. [Abstract] [Full Text] [PDF]

				S. A. Borg, K. E. Kerry, L. Baxter, J. A. Royds, and T. H. Jones Expression of Interleukin-6 and Its Effects on Growth of HP75 Human Pituitary Tumor Cells J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4938 - 4944. [Abstract] [Full Text] [PDF]

				C. P. Castro, A. C. Nagashima, M. P. Pereda, V. Goldberg, A. Chervin, P. Largen, U. Renner, G. K. Stalla, and E. Arzt The gp130 Cytokines Interleukin-11 and Ciliary Neurotropic Factor Regulate through Specific Receptors the Function and Growth of Lactosomatotropic and Folliculostellate Pituitary Cell Lines Endocrinology, May 1, 2000; 141(5): 1746 - 1753. [Abstract] [Full Text] [PDF]

				L. Jin, B. G. Burguera, M. E. Couce, B. W. Scheithauer, J. Lamsan, N. L. Eberhardt, E. Kulig, and R. V. Lloyd Leptin and Leptin Receptor Expression in Normal and Neoplastic Human Pituitary: Evidence of a Regulatory Role for Leptin on Pituitary Cell Proliferation J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2903 - 2911. [Abstract] [Full Text]

				M. G. Espey and A. S. Basile Glutamate Augments Retrovirus-Induced Immunodeficiency Through Chronic Stimulation of the Hypothalamic-Pituitary- Adrenal Axis J. Immunol., April 15, 1999; 162(8): 4998 - 5002. [Abstract] [Full Text] [PDF]

				J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, C. J. Strasburger, U. Pagotto, E. Arzt, and G. K. Stalla Interleukin-1{beta} Enhances Interleukin-1 Receptor Antagonist Content in Human Somatotroph Adenoma Cell Cultures J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2429 - 2434. [Abstract] [Full Text]

				T. H. Jones, S. K. Justice, and A. Price Suppression of Tyrosine Kinase Activity Inhibits [3H]Thymidine Uptake in Cultured Human Pituitary Tumor Cells J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2143 - 2147. [Abstract] [Full Text] [PDF]

				D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]